Dr Sarah Carter-WalshawResearch Associate in Ethics
Sarah's principal research interests regard the ethical, social, and legal implications of emerging and hypothetical biotechnologies and interventions.
She is also interested in ethical issues raised by pronatalism, and in the implications of ectogenesis, and of the use of in vitro gametogenesis for reproductive purposes in socially infertile persons (as well as how the intervention would change assisted reproduction in a broader sense).
Sarah Carter-Walshaw graduated with a BA in Philosophy from Roehampton University in 2011 and from the University of Leeds in 2013 with an MA in Health Care Ethics. She then completed a PhD in Bioethics and Medical Jurisprudence at the University of Manchester in 2017. Her thesis, entitled ‘Moral Bioenhancement: An Ethico-Legal Exploration of the Motivational Role of Money, Health, and Duty’, reflected her interest in hypothetical interventions and the ethical issues that they raise; she passed with no corrections. Throughout her time at Manchester, Sarah also worked as an ethics tutor and facilitator in the Leeds Institute of Medical Education at the University of Leeds.
Sarah is currently a research associate on the Wellcome Funded Project: The Donation and Transfer of Reproductive Materials where she is exploring ethical issues related to ectogenesis and to the use of in vitro gametogenesis for reproductive purposes.
Could Moral Enhancement Interventions be Medically Indicated?
Carter, S. 12/2017 In: Health Care Analysis. 25, 4, p. 338-353. 16 p.
A Kantian ethics approach to moral bioenhancement
Carter, S. 11/2017 In: Bioethics. 31, 9, p. 683-690. 8 p.
Putting a price on empathy: against incentivising moral enhancement
Carter, S. 1/10/2015 In: Journal of Medical Ethics. 41, 10, p. 825–829. 5 p.